The coordinate regulation of DNA synthesis and suppression of apoptosis was investigated in a rat hepatocyte cell culture system which supports high level induction of DNA synthesis by the peroxisome proliferator, methylclofenapate ( 
Introduction
The liver is capable of extraordinary homeostatic responses (2) , but the physiological mechanisms which control the liver, including the balance between cell growth and death, are as yet unclear. Liver growth can occur either as regeneration, e.g. after chemically-induced hepatocyte cell death or partial hepatectomy, or as an augmentative process in the absence of gross cell death (3) . Whereas regenerative growth results in the maintenance of the pre-existing liver/body weight ratio, augmentative growth is of especial interest as it results in hepatomegaly, with an increased liver/body weight ratio. Chemical agents such as peroxisome proliferators or barbiturates produce augmentative liver growth, and this is associated with their action as tumour promoters and non-genotoxic carcinogens (4) (5) (6) (7) (8) .
The coordinated regulation and balance between apoptosis and cell growth has been shown to be an important component of liver growth regulation for phenobarbital (PB) and peroxisome proliferators, and recent data has emphasized the importance of this balance of control mechanisms in the growth of preneoplastic foci and, hence, in chemical carcinogenesis (7, 9) . Moreover, it is clear that for the barbiturates and peroxisome proliferators, the distinct mechanisms of promotion and carcinogenesis have functional implications in the processes of promotion and growth of precancerous lesions; for example, the peroxisome proliferator, Wy-14,643, can lead to DNA synthesis in up to 30% of hepatoctyes where PB has a much weaker effect on DNA synthesis (10) . Nafenopin and other peroxisome proliferators induce a subtype of altered foci in rat liver distinct to that promoted by PB (11) , and the peroxisome proliferators show initiator specificity as promoting agents (12) , where PB does not. Thus, the nature of the balance between cell growth and death in augmentative liver growth may be a crucial factor in determining the chronic consequences of perturbation of liver homeostasis.
It has been difficult to dissect the mechanistic basis of the balance between cell growth and death in the absence of a valid in vitro culture system. Thus, although cytochrome P450 4A and peroxisomal enzyme RNAs are highly induced by peroxisome proliferators in primary cultures of hepatocytes (13) , induction of DNA synthesis is only 2-to 3-fold in vitro (1, 14) compared with 10-to 30-fold in vivo. Low levels of induction of DNA synthesis have been reported previously for PB (15) (16) (17) both in vivo and in vitro. The ability of peroxisome proliferators to suppress apoptosis in primary hepatocytes and liver cell lines has been described recently (18, 19) ; however, cell-cycle control is compromised in cell lines, and so the coordinate regulation of DNA synthesis and apoptosis is little understood. PB has been shown to suppress TGF-β-induced apoptosis, but paradoxically inhibits entry into S-phase in primary hepatocytes (19) , whereas in a PB-dependent cell line, the presence of PB can, paradoxically, lead to apoptosis (20) . Thus, the balance between cell growth and death which is so crucial to organ homeostasis in augmentative liver growth remains poorly characterized in an in vitro hepatocyte system.
We have recently developed a hepatocyte culture system which is highly responsive to peroxisome proliferators, as judged by high level induction of cytochrome P450 and peroxisomal β-oxidation RNAs (13) , and replicative DNA synthesis (1) . We have used the availability of this cell culture system to study whether cell growth and suppression of apoptosis are coordinated in the same manner by two classes of augmentative liver growth agents, and non-genotoxic carcinogens, PB and peroxisome proliferators.
Materials and methods

Animals and reagents
Male Wistar rats (180-240 g) and Dunkin-Hartley guinea-pigs were obtained from Queens Medical Centre, Nottingham. All reagents were of the highest available quality. Collagenase H was obtained from Boehringer Mannheim.
Hepatocyte culture
The procedure is as described previously (2, 14) . Briefly, rats were killed by inhalation of ether, and the hepatic portal vein and superior vena cava cannulated. Livers were perfused in situ with Krebs Ringer phosphate buffer (KRPB; 150 mM NaCl, 5 mM KCl, 1.2 mM KH 2 PO 4 , 0.62 mM MgCl 2 , 0.62 mM MgSO 4 , 3.7 mM NaHCO 3 , 4.8 mM Na 2 HPO 4 and 10 mg/l phenol red pH 7.4) for 10 min, followed by 5 min perfusion with Krebs Ringer hydrogencarbonate buffer (KRHB; 142 mM NaCl, 4.4 mM KCl, 1.2 mM KH 2 PO 4 , 0.62 mM MgCl 2 , 24 mM NaHCO 3 and 10 mg/l phenol red pH 7.4). The liver was then perfused with KRHB containing 3.8 mM CaCl 2 and 0.48 mg/ml collagenase H in a recirculating system until the liver was digested. Cells were washed three times by centrifugation at 50 g and plated at 2ϫ10 6 viable cells per 25 cm 2 Falcon culture flask. Viability was typically 85-95%. Isolation of guinea-pig hepatocytes was as described above, except that the gall bladder was ligatured and excised prior to perfusion with collagenase.
Cells were cultured in 'Complete Leibowitz-15Ј media [CL-15; 8.3% (v/v) foetal bovine serum, 8.3% (v/v) tryptose phosphate broth, 41.3 U/ml penicillin-G, 5.6 mM streptomycin sulphate, 1.65 mM glutamine, 10 -6 M insulin, 10 -5 hydrocortisone hemisuccinate in Leibowitz media] at 37°C in air. The medium was changed 4 h after initial plating, followed by a change the following morning and each 24 h thereafter. PB or methylclofenapate (MCP) were added after 24 h in culture, and included in all subsequent media changes. Dimethylsulfoxide (DMSO) and dimethylformamide (DMF) vehicles were used at a final concentration of 0.25% (v/v).
Measurement of replicative DNA synthesis
Two methods were used for measuring DNA synthesis; incorporation of either bromodeoxyuridine (BrdUrd) or [ 3 H]thymidine. BrdUrd was added at a concentration of 3 µg/ml for the indicated period of time and cells were subsequently rinsed for 30 s in phosphate-buffered saline, and fixed for 20 min at -20°C in 70% ethanol (v/v), 50 mM glycine pH 2, followed by rinsing in water, and air drying. Immunocytochemical detection of the BrdUrd was essentially as described in the Amersham immunodetection, except that cellular DNA was denatured by incubation for 20 min in 0.5 M NaOH, 1.5 M NaCl, followed by incubation in 0.5 M Tris-HCl, 1.5 M NaCl pH 7.4 for 20 min. For detection of cells labelled with [ 3 H]thymidine, cells were fixed for 10 min, and then 1 h, in glacial acetic acid (25% v/v) in ethanol at -20°C, followed by washing in water, and air drying. Flasks were dipped in Kodak K2 emulsion gel, exposed for an appropriate time and developed. The number of cells undergoing DNA synthesis was recorded as the labelling index [(number of labelled cells/total number of cells)ϫ100]; typically Ͼ2400 cells were measured at each data point. 
Measurement of apoptosis
Statistics
Differences between individual groups were analysed by Student's t-test and a probability of P Ͻ 0.05 was deemed significant. Each analysis was performed on multiple plates from within one experiment, and each experiment was repeated on at least two occasions.
Results
PB and MCP induce DNA synthesis in vitro
Primary rat hepatocytes were treated with the peroxisome proliferator, MCP (100 µM), and replicative DNA synthesis visualized by immunocytochemical localisation of incorporated BrdUrd. The peroxisome proliferator, MCP, typically induced DNA synthesis about 8-to 10-fold (1; data not shown). In contrast, PB had a lesser effect on DNA synthesis, typically inducing DNA synthesis to 300% of control values ( Figure  1A ). This is consistent with in vivo studies, where PB has less effect on mitogenesis than peroxisome proliferators (8, 17) . Moreover, the time course of induction of DNA synthesis by PB was considerably later than that mediated by MCP, where DNA synthesis peaked 24 h after dosing ( Figure 1A) . Hepatocytes which had undergone DNA synthesis in control-and PB-treated cultures were characterized to determine their nuclearity ( Figure 1B) . In control cultures, between 3 and 4% of labelled hepatocytes were binucleated, whereas in hepatocytes treated with PB, 6 and 9% of labelled hepatocytes were binucleated at 36 and 42 h after dosing. These results in PB-treated cells were significantly different from control cultures (P Ͻ 0.05).
The stability of the DNA labelled during S-phase was compared for the precursors, BrdUrd and [ 3 H]thymidine. As shown in Figure 2 , hepatocytes were treated with MCP to induce DNA synthesis, exposed to either BrdUrd or [ 3 H]thymidine between 6 and 30 h after dosing, and maintained in the presence of MCP. The labelling index was determined at various times thereafter. There was no significant difference in the initial labelling index obtained using [ (18, 20) . The hepatocyte mitogen, epidermal growth factor (EGF), had no effect on the level of apoptosis in control cultures ( Figure 3A) , nor did the DMSO vehicle. However, MCP (100 µM) reduced the incidence of cells with condensed chromatin by~70%. The effect was dose related ( Figure 3B) , with a maximal effect at 100 µM; this is identical to the peak of the dose-response measured when measuring induction of CYP4A1 mRNA (13) . While control cultures of hepatocytes degenerated in 4-5 days, the suppression of apoptosis by MCP was associated with maintenance of the hepatocyte monolayer over extended periods ( Figure 4A and B) . The monolayer of hepatocytes after 14 days had a morphology typical of well-differentiated hepatocytes.
The reversibility of suppression of apoptosis by peroxisome proliferators was investigated. Hepatocytes were therefore cultured in the presence of MCP for 14 days, and the culture medium replaced with or without the presence of peroxisome proliferator. As shown in Figure 6A , after removal of MCP from the medium, there was a rapid (7 h) induction of apoptosis. Thus, suppression of apoptosis by peroxisome proliferators is reversible.
Hydrocortisone, or an alternative glucocorticoid, is required for induction of enzymes of peroxisomal β-oxidation and replicative DNA synthesis by peroxisome proliferators in primary cultures of rat hepatocytes (1, 22) ; this is associated with induction of the peroxisome proliferator activated receptor α(PPARα) (1,23). We investigated whether hydrocortisone was necessary for the suppression of apoptosis by peroxisome proliferators ( Figure 5A ). In the presence of hydrocortisone, MCP significantly suppressed apoptosis, but in the absence of hydrocortisone, there was no significant difference between control and MCP treated cultures. In contrast, the presence or absence of hydrocortisone had no effect on the ability of 1524 phenobarbitone to suppress apoptosis (Figure 5a) . Thus, glucocorticoids are necessary for suppression of apoptosis by MCP.
Rats and mice are known to be highly sensitive to peroxisome proliferators, whereas guinea-pigs are known to be much less sensitive (24) . We therefore examined whether peroxisome proliferators could suppress apoptosis in the guinea-pig. As guinea-pig hepatocytes are unable to synthesize vitamin C and are normally cultured in the presence of this vitamin, cultures were performed in the presence and absence of vitamin C. MCP failed to suppress apoptosis in guinea-pig hepatocytes ( Figure 5B ) in either the presence or absence of vitamin C, although in concurrent experiments, MCP suppressed apoptosis in rat hepatocytes (data not shown). Guinea-pig hepatocytes have a lower endogenous level of apoptosis and are maintained as a monolayer culture of hepatocytes over extended periods (Ͼ7 days); the peroxisome proliferator had no effect on the maintenance of the monolayer (data not shown).
PB suppresses apoptosis in hepatocytes in vitro
PB suppresses apoptosis in a dose-dependent manner, as shown in Figure 3C . The suppression of apoptosis was also associated with maintenance of the hepatocyte monolayer ( Figure 4C ), although the hepatocyte monolayer was associated with a distinct morphology. Notably, the bright refractile borders along hepatocytes which are evident with peroxisome proliferators is absent from PB-treated cultures ( Figure 4A-C) .
Concordance of DNA synthesis and apoptosis
Cells were labelled with [ 3 H]thymidine during the acute phase of DNA synthesis induced by either MCP or PB, and maintained for 14 days. Figure 2 demonstrates that there is no selective loss of a labelled (or unlabelled) cell population, as the ratio of labelled:unlabelled cells stays constant, and the hepatocyte monolayer remains confluent (Figure 4) . The xenobiotic-containing medium was replaced with medium lacking xenobiotic, and the cells were fixed during the peak of the apoptotic response ( Figure 6A ). Cells were duallabelled with Hoechst 33258 for chromosome condensation and autoradiography to visualize those cells which had undergone DNA synthesis. After maintenance of hepatocytes with MCP for 14 days, followed by withdrawal ( Figure 6A ), there were no hepatocytes undergoing apoptosis in Ͼ1000 labelled hepatocytes. In contrast, the apoptotic index in the culture was 1.7% at 7 h after withdrawal of MCP. Thus, the cells which were stimulated into undergoing DNA synthesis by peroxisome proliferators during the initial 30 h period are differentially resistant to induction of apoptosis caused by withdrawal of peroxisome proliferators. Although PB and MCP suppress apoptosis, it is not clear that these are operating through the same mechanism. We therefore maintained hepatocytes for 14 days on either PB or MCP, and tested whether PB and MCP could substitute for each other to maintain the hepatocyte monolayer. As represented in Figure 6B -E, when cells are maintained by MCP and PB is substituted in the medium, the monolayer degenerates rapidly. However, when cells are maintained by PB and MCP is substituted for PB in the medium, the monolayer is maintained. Thus, the effects of PB and MCP on suppression of apoptosis are distinct.
Discussion
Our studies demonstrate that both the peroxisome proliferator, MCP and the barbiturate, PB, can induce DNA synthesis, and suppress apoptosis in cultured hepatocytes (19; this study), but that the effects of the two agents are distinct. MCP is a potent mitogen, inducing DNA synthesis up to 10-fold above control levels (1), whereas phenobarbitone is only weakly mitogenic-2-to 3-fold above control levels. Moreover, the time course of induction of DNA synthesis by the two agents is markedly different-MCP induces DNA synthesis to peak levels~24 h after dosing (1), whereas PB-induced DNA synthesis peaks at 36 h after dosing. It is notable that this time point is coincident with induction of DNA synthesis in control cultures. These results are consistent with previous studies on the induction of DNA synthesis by barbiturates in vitro (15, 16) , and are consistent with a relatively small induction of DNA synthesis by barbiturates in the liver (17) , as compared with peroxisome proliferators (8) . An additional strand of evidence to illustrate the difference in the mechanisms of mitogenic response caused by PB and peroxisome proliferators is derived from analysis of the nuclearity of hepatocytes which had undergone DNA synthesis. In our previous studies, we have shown that peroxi-1525 some proliferator-induced DNA synthesis leads to a population of hepatocytes with a lower incidence of binucleates than control cells (1), whereas PB-treatment of cells leads to a population of labelled cells with 2-to 3-fold higher incidence of binucleates than control cultures ( Figure 1B ). This is entirely consistent with a role for endogenous growth factors playing a role in PB-mediated mitogenesis.
Whilst analysing the suitability of nucleotide analogues for long-term stability when incorporated into DNA, we noted that both BrdUrd and [ 3 H]thymidine gave equivalent measures of labelling indices as a measure of DNA synthesis, immediately after the labelling period (Figure 1 ). This is consistent with previous reports demonstrating the equivalence of the two methods in vivo (25) over a short time period. However, we were unable to ascertain from the literature whether the two nucleosides gave equivalent results at a few weeks subsequent to the labelling period, although it is clear that some quantity of both nucleosides persist in labelled DNA in vivo. A direct comparison of residual incorporated nucleoside revealed that the number of BrdUrd-labelled hepatocytes declined by 42% over 14 days compared with cells labelled with [ 3 H]thymidine. One explanation for the decline in the number of BrdUrd-labelled cells is selective removal of these cells, presumably as a result of the DNA damage caused by incorporation of the base analogue. If this hypothesis is true, then BrdUrd which has been incorporated into DNA may not be stable even in the medium term and the use of this base analogue may give misleading results. As a consequence of these studies, we used [ 3 H]thymidine for studies where medium-term stability of labelled DNA was required.
MCP and PB suppressed apoptosis, with maximal effects at 100 µM and 2 mM, respectively. Suppression of apoptosis was associated with maintenance of the hepatocyte cultures over a period of 14 days, while control cultures showed marked deterioration. The suppression of apoptosis by MCP was reversible ( Figure 6A )-after removal of the peroxisome proliferator, there was a rapid rise in apoptosis, peaking at 7 h after changing the media. The conventional view is that peroxisome proliferators act via the PPAR α-mediated induction of transcription (26); thus, the speed of this response is surprising. Possible explanations include the continuous transcription of a suppressor of apoptosis which is turned over rapidly; however, there is also the possibility that ligand-bound PPARα adopts an activated conformation (27) and thereby interacts with a nuclear protein to inhibit apoptosis. Consistent with a paramount role for PPARα, glucocorticoids are known to induce the level of this protein in hepatocytes in culture (1, 23) . This is associated with a requirement for glucocorticoids in order for hepatocyte cultures to support peroxisome proliferation (22) . In this system, 10 -5 M hydrocortisone was required for the suppression of apoptosis by peroxisome proliferators. This effect is specific to peroxisome proliferators, as the presence or absence of hydrocortisone had no significant effect on phenobarbitone-induced suppression of mitogenesis. Thus, hydrocortisone is necessary for peroxisome proliferation and suppression of apoptosis by peroxisome proliferators in hepatocyte culture.
Species differences in peroxisome proliferation are well documented (24, (28) (29) (30) , and are of fundamental importance to hazard assessment for peroxisome proliferators. The guineapig is a well characterized model species which is highly resistant to the effects of peroxisome proliferators (24, 31) . It has been reported that the peroxisome proliferators, MCP, Wy-14,643 and nafenopin, suppress apoptosis in guinea-pig hepatocytes (28) . Our results demonstrate unequivocally that there is no suppression of apoptosis in guinea-pig hepatocytes treated with the potent peroxisome proliferator, MCP, in our system. James and Roberts (28) used a different culture media and peroxisome proliferators, whereas our data were obtained in CL-15 media and MCP; in view of the known mechanism of action of peroxisome proliferators through the PPARα receptor, it seems unlikely that the choice of agonist would have a significant effect on this outcome, since MCP has been demonstrated to be highly potent. However, the cell culture medium may have a significant role in changing the capacity of the hepatocytes to respond to peroxisome proliferators; for example, James and Roberts reported a much higher basal rate of apoptosis in guinea-pig hepatocytes (28) . Since the guineapig is known to show no change in liver weight after treatment with peroxisome proliferators (24, (29) (30) (31) , it seems likely that there is no or minimal change in apoptosis in the liver after treatment with peroxisome proliferators in vivo. The recent discovery that the guinea-pig has a functional PPARα, which is expressed at low levels in liver, was accompanied by the demonstration that PPARα ligands can induce physiological effects (hypolipidaemia) in guinea-pig (32) .
This cell culture system has been demonstrated to support both high-level induction of DNA synthesis and suppression of apoptosis by peroxisome proliferators. The high level induction of DNA synthesis by peroxisome proliferators has recently been confirmed by another group (33) . We are currently undertaking investigations into the coordinate regulation of DNA synthesis and apoptosis by peroxisome proliferators.
